動態

• 

  Mary Grace N. Tamio   shared news

  在 April 16 2024 at 08:19 PM 已編輯 public

  Does ICS treatment increase the risk of pneumonia in asthma?
  
  #ICStreatment #pneumonia #asthma #journals #articles
  
  More info | ⬇️

  

  Does ICS treatment increase the risk of pneumonia in asthma?

  Patients with asthma have an increased risk of being hospitalised for pneumonia. For example, in a study based on the Resp...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 March 28 2024 at 09:31 PM 已編輯 public

  Paradoxical bronchodilator response is associated with increased risk of asthma exacerbations
  
  #asthma #paradoxicalbronchodilator #journals #articles
  
  More info | ⬇️

  

  Paradoxical bronchodilator response is associated with increased risk of asthma exacerbations.

  Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2024 Elsevier B.V., its licensors, an...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 March 13 2024 at 08:31 PM 已編輯 public

  Eosinophilia and wheeze: thinking beyond asthma
  
  #eosinophilia #wheeze #asthma #journals #articles
  
  More info | ⬇️

  

  Eosinophilia and wheeze: thinking beyond asthma

  A previously well, 9-year-old girl was referred to the Paediatric Asthma Clinic with a 12-month history of cough, dyspnoea...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 September 01 2023 at 04:05 PM 已編輯 public

  Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea
  
  #fluticasonefuroate #asthma #chronicobstructivepulmonarydisease #pulmonarydisease #journals #articles
  
  More info | ⬇️

  

  Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea

  Fluticasone furoate/vilanterol (FF/VI; RELVAR ELLIPTA) is approved in Korea for patients with asthma or chronic obstructiv...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 21 2023 at 08:30 PM 已編輯 public

  Effects of Dupilumab for Asthma-chronic Obstructive Pulmonary Disease Overlap
  
  #dupilumab #asthma #pulmonarydisease #journals #articles
  
  More info | ⬇️

  Effects of Dupilumab for Asthma-chronic Obstructive Pulmonary Disease Overlap

  1. Japanese Respiratory Society. The JRS guidelines for management of ACO 2018. Tokyo: Medical Revie...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享